Samil Pharmaceutical Co., Ltd.(KR:000520)
â‚©6,720.00-260.00 (-3.72%)
KR:000520
Samil Pharmaceutical Co., Ltd. financials statements
â‚©6,720.00
At close:-260.00 (-3.72%)
Want to see KR:000520 full AI Analyst Report?
Samil Pharmaceutical Co., Ltd. (000520) Ratios
Samil Pharmaceutical Co., Ltd. Ratios
KR:000520's free cash flow for Q2 2026 was ₩-5.91B. For the 2026 fiscal year, KR:000520's free cash flow was decreased by ₩-460.65M and operating cash flow was ₩-5.45B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.44 | 0.86 | 0.48 | 0.56 | 0.63 |
| Quick Ratio | 0.25 | 0.53 | 0.29 | 0.38 | 0.43 |
| Cash Ratio | 0.03 | 0.05 | 0.01 | 0.01 | 0.03 |
| Solvency Ratio | -0.09 | 0.01 | 0.03 | 0.02 | -0.00 |
| Operating Cash Flow Ratio | -0.03 | 0.02 | 0.07 | 0.03 | 0.01 |
| Short-Term Operating Cash Flow Coverage | -0.04 | 0.04 | 0.09 | 0.05 | 0.02 |
| Net Current Asset Value | â‚© -156.38B | â‚© -127.60B | â‚© -161.74B | â‚© -156.10B | â‚© -83.95B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.44 | 0.38 | 0.47 | 0.45 | 0.55 |
| Debt-to-Equity Ratio | 1.23 | 0.85 | 1.38 | 1.27 | 1.91 |
| Debt-to-Capital Ratio | 0.55 | 0.46 | 0.58 | 0.56 | 0.66 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.32 | 0.28 | 0.36 | 0.33 |
| Financial Leverage Ratio | 2.79 | 2.24 | 2.90 | 2.84 | 3.44 |
| Debt Service Coverage Ratio | -0.05 | 0.10 | 0.08 | 0.10 | 0.06 |
| Interest Coverage Ratio | -2.73 | 0.02 | 1.83 | 0.94 | 0.06 |
| Debt to Market Cap | 0.79 | 0.62 | 1.78 | 1.41 | 1.18 |
| Interest Debt Per Share | 8132.69 | 8626.95 | 12527.84 | 11751.44 | 9524.72 |
| Net Debt to EBITDA | -14.70 | 16.74 | 16.93 | 15.26 | 19.75 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.06% | 36.83% | 36.78% | 37.56% | 36.49% |
| EBIT Margin | -11.38% | 0.66% | 2.53% | 2.96% | 1.07% |
| EBITDA Margin | -5.10% | 3.94% | 5.26% | 5.74% | 4.58% |
| Operating Profit Margin | -11.38% | 0.05% | 3.30% | 2.24% | 0.30% |
| Pretax Profit Margin | -17.66% | -1.64% | 0.73% | 0.59% | -3.55% |
| Net Profit Margin | -16.44% | -2.56% | 0.85% | -0.02% | -3.98% |
| Continuous Operations Profit Margin | -16.44% | -2.56% | 0.85% | -0.02% | -3.98% |
| Net Income Per EBT | 93.09% | 155.81% | 116.84% | -2.67% | 112.29% |
| EBT Per EBIT | 155.23% | -3195.87% | 22.00% | 26.34% | -1191.11% |
| Return on Assets (ROA) | -9.31% | -1.42% | 0.45% | -0.01% | -2.36% |
| Return on Equity (ROE) | -25.96% | -3.20% | 1.30% | -0.02% | -8.13% |
| Return on Capital Employed (ROCE) | -12.84% | 0.04% | 3.20% | 1.79% | 0.38% |
| Return on Invested Capital (ROIC) | -6.80% | 0.03% | 1.98% | -0.03% | 0.20% |
| Return on Tangible Assets | -9.45% | -1.44% | 0.45% | -0.01% | -2.38% |
| Earnings Yield | -16.80% | -2.38% | 1.70% | -0.03% | -5.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.64 | 6.14 | 5.48 | 5.26 | 4.31 |
| Payables Turnover | 7.45 | 7.24 | 5.91 | 8.21 | 9.98 |
| Inventory Turnover | 4.10 | 3.99 | 3.82 | 4.53 | 3.53 |
| Fixed Asset Turnover | 0.87 | 0.87 | 0.81 | 0.77 | 1.30 |
| Asset Turnover | 0.57 | 0.56 | 0.53 | 0.50 | 0.59 |
| Working Capital Turnover Ratio | -3.55 | -4.27 | -2.70 | -3.50 | -3.78 |
| Cash Conversion Cycle | 104.76 | 100.50 | 100.41 | 105.49 | 151.58 |
| Days of Sales Outstanding | 64.75 | 59.44 | 66.58 | 69.44 | 84.65 |
| Days of Inventory Outstanding | 89.02 | 91.44 | 95.60 | 80.50 | 103.50 |
| Days of Payables Outstanding | 49.01 | 50.39 | 61.76 | 44.44 | 36.57 |
| Operating Cycle | 153.77 | 150.89 | 162.17 | 149.93 | 188.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -285.20 | 144.02 | 820.11 | 298.52 | 102.46 |
| Free Cash Flow Per Share | -636.15 | -168.06 | -882.91 | -3198.16 | -2290.40 |
| Dividend Paid and CapEx Coverage Ratio | -0.81 | 0.46 | 0.48 | 0.08 | 0.04 |
| Capital Expenditure Coverage Ratio | -0.81 | 0.46 | 0.48 | 0.09 | 0.04 |
| Operating Cash Flow Coverage Ratio | -0.04 | 0.02 | 0.07 | 0.03 | 0.01 |
| Operating Cash Flow to Sales Ratio | -0.03 | 0.01 | 0.06 | 0.02 | 0.01 |
| Free Cash Flow Yield | -6.57% | -1.28% | -12.89% | -39.75% | -30.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.95 | -42.01 | 58.97 | -3957.74 | -19.61 |
| Price-to-Sales (P/S) Ratio | 0.98 | 1.08 | 0.50 | 0.62 | 0.78 |
| Price-to-Book (P/B) Ratio | 1.54 | 1.34 | 0.77 | 0.89 | 1.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.23 | -78.25 | -7.76 | -2.52 | -3.31 |
| Price-to-Operating Cash Flow Ratio | -33.98 | 91.31 | 8.35 | 26.95 | 74.00 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.11 | -0.01 | 39.79 | 0.04 |
| Enterprise Value Multiple | -33.90 | 44.04 | 26.42 | 26.12 | 36.79 |
| Enterprise Value | 363.49B | 381.42B | 273.08B | 269.31B | 226.37B |
| EV to EBITDA | -33.90 | 44.04 | 26.42 | 26.12 | 36.79 |
| EV to Sales | 1.73 | 1.74 | 1.39 | 1.50 | 1.69 |
| EV to Free Cash Flow | -26.89 | -126.21 | -21.60 | -6.05 | -7.15 |
| EV to Operating Cash Flow | -59.99 | 147.27 | 23.25 | 64.83 | 159.77 |
| Tangible Book Value Per Share | 6014.06 | 9487.41 | 8728.44 | 8816.61 | 4660.59 |
| Shareholders’ Equity Per Share | 6272.04 | 9793.91 | 8925.25 | 9042.01 | 4754.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | -0.56 | -0.17 | 1.03 | -0.12 |
| Revenue Per Share | 9901.10 | 12217.07 | 13709.38 | 12912.40 | 9707.63 |
| Net Income Per Share | -1627.95 | -313.01 | 116.15 | -2.03 | -386.63 |
| Tax Burden | 0.93 | 1.56 | 1.17 | -0.03 | 1.12 |
| Interest Burden | 1.55 | -2.50 | 0.29 | 0.20 | -3.30 |
| Research & Development to Revenue | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 |
| SG&A to Revenue | 0.20 | 0.16 | 0.31 | 0.16 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.17 | -0.46 | 7.06 | -146.85 | -0.26 |
Currency in KRW

